These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 19289394)
1. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394 [TBL] [Abstract][Full Text] [Related]
2. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations. Ghalamkarpour A; Morlot S; Raas-Rothschild A; Utkus A; Mulliken JB; Boon LM; Vikkula M Clin Genet; 2006 Oct; 70(4):330-5. PubMed ID: 16965327 [TBL] [Abstract][Full Text] [Related]
3. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Connell FC; Ostergaard P; Carver C; Brice G; Williams N; Mansour S; Mortimer PS; Jeffery S; Hum Genet; 2009 Jan; 124(6):625-31. PubMed ID: 19002718 [TBL] [Abstract][Full Text] [Related]
5. Three children with Milroy disease and de novo mutations in VEGFR3. Carver C; Brice G; Mansour S; Ostergaard P; Mortimer P; Jeffery S; Clin Genet; 2007 Feb; 71(2):187-9. PubMed ID: 17250670 [No Abstract] [Full Text] [Related]
7. A novel mutation in the conserved sequence of vascular endothelial growth factor receptor 3 leads to primary lymphoedema. Dai T; Li B; He B; Yan L; Gu L; Liu X; Qi J; Li P; Zhou X J Int Med Res; 2018 Aug; 46(8):3162-3171. PubMed ID: 29896974 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Irrthum A; Devriendt K; Chitayat D; Matthijs G; Glade C; Steijlen PM; Fryns JP; Van Steensel MA; Vikkula M Am J Hum Genet; 2003 Jun; 72(6):1470-8. PubMed ID: 12740761 [TBL] [Abstract][Full Text] [Related]
10. Milroy's primary congenital lymphedema in a male infant and review of the literature. Kitsiou-Tzeli S; Vrettou C; Leze E; Makrythanasis P; Kanavakis E; Willems P In Vivo; 2010; 24(3):309-14. PubMed ID: 20555004 [TBL] [Abstract][Full Text] [Related]
11. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells. Pan MR; Chang TM; Chang HC; Su JL; Wang HW; Hung WC J Cell Sci; 2009 Sep; 122(Pt 18):3358-64. PubMed ID: 19706680 [TBL] [Abstract][Full Text] [Related]
12. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Irrthum A; Karkkainen MJ; Devriendt K; Alitalo K; Vikkula M Am J Hum Genet; 2000 Aug; 67(2):295-301. PubMed ID: 10856194 [TBL] [Abstract][Full Text] [Related]
13. [Identification of VEGFR3 gene mutation in a Chinese family with autosomal dominant primary congenital lymphoedema]. Sheng JQ; Zeng F; Li C; Liu JY; Wang Q; Liu MG Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):371-5. PubMed ID: 20677139 [TBL] [Abstract][Full Text] [Related]
14. Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2. Rezaie T; Ghoroghchian R; Bell R; Brice G; Hasan A; Burnand K; Vernon S; Mansour S; Mortimer P; Jeffery S; Child A; Sarfarazi M Eur J Hum Genet; 2008 Mar; 16(3):300-4. PubMed ID: 18197197 [TBL] [Abstract][Full Text] [Related]
15. Severe congenital lymphoedema not caused by mutations in known lymphoedema genes. Greenberger S; Reznik-Wolf H; Ghalamkarpour A; Marek-Yagel D; Vikkula M; Pras E Br J Dermatol; 2010 Dec; 163(6):1358-60. PubMed ID: 20804492 [No Abstract] [Full Text] [Related]
16. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. Gordon K; Spiden SL; Connell FC; Brice G; Cottrell S; Short J; Taylor R; Jeffery S; Mortimer PS; Mansour S; Ostergaard P Hum Mutat; 2013 Jan; 34(1):23-31. PubMed ID: 23074044 [TBL] [Abstract][Full Text] [Related]
17. A Novel Missense Mutation in FLT4 Causes Autosomal Recessive Hereditary Lymphedema. Melikhan-Revzin S; Kurolap A; Dagan E; Mory A; Gershoni-Baruch R Lymphat Res Biol; 2015 Jun; 13(2):107-11. PubMed ID: 26091405 [TBL] [Abstract][Full Text] [Related]
18. Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2. Ghalamkarpour A; Debauche C; Haan E; Van Regemorter N; Sznajer Y; Thomas D; Revencu N; Gillerot Y; Boon LM; Vikkula M J Pediatr; 2009 Jul; 155(1):90-3. PubMed ID: 19394045 [TBL] [Abstract][Full Text] [Related]
19. The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases. Monaghan RM; Page DJ; Ostergaard P; Keavney BD Cardiovasc Res; 2021 Jul; 117(8):1877-1890. PubMed ID: 33067626 [TBL] [Abstract][Full Text] [Related]
20. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation. Mizuno S; Yamada Y; Yamada K; Nomura N; Wakamatsu N Congenit Anom (Kyoto); 2005 Jun; 45(2):59-61. PubMed ID: 15904433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]